Letermovir successfully used for secondary prophylaxis in a heart transplant recipient with ganciclovir ‐resistant cytomegalovirus syndrome (UL97 mutation)

Transplant Infectious Disease,Volume 0, Issue ja, -Not available-.

Source: Transplant Infectious Disease - July 10, 2018 Category: Transplant Surgery Authors: Pearlie P Chong , Dagny Teiber , Bonnie C Prokesch , Reuben J Arasaratnam , Matthias Peltz , Mark H Drazner , Sonia Garg Source Type: research